News

When combination antiretroviral therapy does not lead to sufficient HIV suppression, a new study finds that PrEP can become cost-effective for couples with differing HIV status who are trying to conceive.

Despite promising early results, dolutegravir monotherapy should no longer be used as HIV maintenance therapy, a new study concludes.

The results of a new study on drug repurposing indicate that the process may bring new hope in the battle against infectious diseases.

People living with HIV are twice as likely to develop cardiovascular disease than noninfected individuals, and are more likely to have incident heart failure than the general population, even after adjustment for demographics and cardiovascular risk factors.

Despite the increase of live poultry-related Salmonella outbreaks, environmental sampling at hatcheries is not routinely conducted leaving the outbreak source unknown.

Maraviroc’s safety profile makes it a potential drug of choice for those at risk of contracting HIV, but a recent study raises questions about how well it works.

Investigators say a bacteriophage trial that was cut short due to the therapy’s slow effect on infected burns still yielded important insights.

Investigators have identified Marburg virus in Sierra Leone bats, marking the first time the hemorrhagic fever has been discovered in West Africa.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

While the United States has seen significant increases in pre-exposure prophylaxis (PrEP) use among those at risk for HIV infection, PrEP uptake rates are still low overall in men who have sex with men, as well as in transgender individuals. A new study examines how a behavior model may help increase PrEP use in these at-risk groups.

As health officials in Nebraska monitor an American potentially exposed to Ebola, outbreak response activities have been impeded in the DRC following the cutting of internet connections by the government.

When taken consistently, PrEP can reduce the risk of HIV infection by 92%. So why aren’t more health care professionals prescribing it to adolescents, who continue to have an increased HIV incidence rate nationally?

Updated guidelines will hopefully spur more clinicians to test for and treat influenza in people with symptoms whether they’re high risk or not.

Yemen is currently experiencing the largest recorded cholera outbreak in history, and investigators have determined that migration from Eastern Africa brought the outbreak strain into the nation.

Understanding the spiral of usage and resistance might help us stop prescribing practices that fuel AMR.

Patients with the hepatitis C virus who are on Medicaid in Oregon can expect to receive curative treatment in 2019, without having to wait for liver damage to set in.

After 6 NIH hospital patients developed infections from waterborne bacteria, investigators found contamination in facility pipes and faucets.

The FDA approved the vaccine in 2016 for adults between the ages of 18 and 64 who are traveling to areas of active cholera transmission.

The FDA has cautioned Genetech, Inc. for processing umbilical cord blood into unapproved human stem cell products that may have contributed to the sickening of 12 people.

Single-tablet regimens may provide better virologic response and control than multiple-tablet regimens for people living with HIV, likely due to a lower pill burden and, subsequently, better medication adherence, according to the results of a new study.

After consulting with experts in the infectious disease space, the Contagion® editorial staff has compiled a list of the top 5 infectious disease concerns to watch in 2019.

We've compiled a list of the top 9 infectious disease outbreaks of 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

The Contagion® editorial staff and members of the editorial board recap the top 8 FDA approvals of 2018.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

With early season flu vaccination rates up from 2017-2018 early season rates, new pediatric influenza deaths around the country are prompting health officials to call for even higher vaccination rates.

The vaccine is approved as a 3-dose series, which consists of a 0.5 mL intramuscular injection, administered at 2, 4, and 6 months of age.

An unlikely, but important infectious disease threat to consider in 2019.